ea0011p816 | Thyroid | ECE2006
Do Cao C
, Mirghani H
, Wemeau JL
, Leteurtre E
, dHerbomez M
, Marchandise X
, Proye C
Much controversy persists over aggressiveness of oncocytic thyroid carcinoma (OTC) and its optimal treatment. The study purpose was to determine prognostic factors for persistent or recurrent disease (PRD) and discuss therapeutic directions.We reviewed the medical records of 81 consecutive patients with OTC among a total of 1729 (4.7%) epithelial thyroid cancers, operated from 1983 to 2003 in our center. Follow-up information was updated. Age ranged from...